InvestorsHub Logo

H2R

Followers 41
Posts 2214
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: Frozen asset post# 12076

Tuesday, 11/02/2021 3:51:06 PM

Tuesday, November 02, 2021 3:51:06 PM

Post# of 12138
Dang, since $2. Nice!! I started around $10, and I am quite happy with the return :))

I'm waiting for the next CC which is planned as of now for Nov. 4th and check their status.

CYRX is executing on growth strategy based on the clinical trials, which feeds eventually into commercial products with much greater revenue, and an expansion strategy with partnering or acquisition for greater territory coverage. It's hard to see them fail, it's just a question of how fast they grow and the EPS turns.

On NWBO, the wait is really long, but with the blended data article I cannot see how the trial with the 'new' endpoints can fail. I believe they have access to funds from different sources, including (very) wealthy individuals who can make sure NWBO does not go BK before top line data/ journal publication. Even if they are really slow, I am betting on positive TLD, journal articles, other news (GMP approval, etc.) to hold up the PPS after TLD, and BLA (in the UK / MHRA first?). It's really long, but I believe it will be quite the return and a positive impact in the fight against cancer (I am in at around $0.27, so already a great return :) ).

Wishing you the best with your investments,

Cheers!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News